Patients with recent-onset atrial fibrillation commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether immediate restoration of sinus ...

Direct current cardioversion for symptomatic atrial fibrillation or flutter is feasible and safe in patients implanted with the Watchman left atrial appendage (LAA) occlusion device, even in the ...

The conventional treatment strategy for patients with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for anticoagulation for three weeks before cardioversion.

A cardioversion procedure can reset your heart to its normal rhythm. There are two types: Electrical cardioversion. Your doctor gives your heart an electrical shock through paddles or patches on your ...

Atrial fibrillation (AFib) is a kind of irregular heartbeat, or arrhythmia. A problem with the electrical signals that control your heart’s pumping action causes it to beat too fast in a pattern that ...

Cardioversion is a procedure used to restore a normal heart rhythm. It’s most often used to treat AFib, the most common type of heart arrhythmia. While some people have success with medications, most ...

Nicholas P. Gall, M.Sc., M.D., M.R.C.P.; Francis D. Murgatroyd, M.A., F.R.C.P., F.A.C.C. From these and subsequent studies, it became clear that cardioversion was ...

The 204 people randomized to IV procainamide (plus electrical cardioversion if necessary, with up to three shocks) showed a 96% rate of conversion to sinus rhythm that was maintained for at least 30 ...

Q-I`ve been treated for an abnormal heartbeat for several months, without too much success. My new doctor advises that an electric shock might be used to correct the beat. It`s a frightening thought.

Pharmacologic cardioversion followed by electrical cardioversion and electrical cardioversion only were found to be safe and effective in patients presenting to the emergency department with recent ...

Early stroke and systemic embolism rates in patients following cardioversion for atrial fibrillation (A-fib) are low and comparable between those receiving warfarin or the novel oral anticoagulant ...